Knight L C, Olexa S A, Malmud L S, Budzynski A Z
J Clin Invest. 1983 Dec;72(6):2007-13. doi: 10.1172/JCI111165.
Fragment E1, a product of plasmic digestion of cross-linked fibrin, binds specifically in vitro to polymerized fibrin but not to fibrinogen. Purified human Fragment E1 was radiolabeled with 125I or 131I by the Iodogen technique. The uptake of radioiodinated Fragment E1 in vitro into forming or preformed clots was demonstrated. Animal biodistribution studies of radioiodinated Fragment E1 showed its rapid removal from the circulation; radioactive catabolites did not reside long in any organ and were excreted in the urine. The uptake in vivo was evaluated in pigs with preexisting venous thrombi of various ages from 1 h up to 5 d at the time of intravenous systemic injection of the tracer. Radioiodinated fibrinogen was also injected into the same animals to compare the uptake of the two tracers. Thrombus-to-blood ratios for Fragment E1 averaged 43:1 (range 10-108) and 29:1 (range 8-107) in thrombi 1-6 h and 1-5 d old, respectively. In contrast, mean thrombus-to-blood ratios for fibrinogen were, in the same time intervals, 26:1 (range 17-41) and 2:1 (range 0.5-3.9), respectively. It is concluded that radioiodinated Fragment E1 is a specific marker of thrombi in vivo: its uptake by fresh thrombi is better than that of labeled fibrinogen and, in contrast to radioiodinated fibrinogen, this fragment is incorporated into old thrombi as well.
交联纤维蛋白经血浆消化产生的片段E1,在体外能特异性结合聚合的纤维蛋白,但不与纤维蛋白原结合。纯化的人片段E1通过碘原技术用125I或131I进行放射性标记。已证实放射性碘化的片段E1在体外能摄取到正在形成或已形成的凝块中。放射性碘化片段E1的动物生物分布研究表明其能迅速从循环中清除;放射性代谢产物在任何器官中停留时间都不长,并随尿液排出。在静脉全身注射示踪剂时,对患有不同年龄(从1小时到5天)静脉血栓的猪进行了体内摄取评估。还将放射性碘化纤维蛋白原注射到同一动物体内,以比较两种示踪剂的摄取情况。片段E1在1 - 6小时和1 - 5天龄血栓中的血栓与血液比值平均分别为43:1(范围10 - 108)和29:1(范围8 - 107)。相比之下,在相同时间间隔内,纤维蛋白原的平均血栓与血液比值分别为26:1(范围17 - 41)和2:1(范围0.5 - 3.9)。结论是放射性碘化片段E1是体内血栓的特异性标志物:它被新鲜血栓摄取的情况优于标记的纤维蛋白原,并且与放射性碘化纤维蛋白原不同,该片段也能掺入陈旧血栓中。